Actively Recruiting
Ocular Fluid Analysis in Patients with Presumed Trematode-Induced Granulomatous Uveitis Undergoing Eye Surgery
Led by Kasr El Aini Hospital · Updated on 2026-10-21
40
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates ocular fluid in patients with presumed trematode-induced granulomatous uveitis PTIGU. It includes patients of any age presenting for anterior chamber AC wash or pars plana vitrectomy to better understand this eye condition. Various clinical and laboratory tests are conducted to exclude other causes of granulomatous uveitis and to collect detailed patient information including age, gender, eye involvement, disease duration, and treatments received. Participants undergo surgeries under general anesthesia, with samples collected from the anterior chamber or vitreous fluid. These samples are stored and analyzed using PCR and DNA sequencing techniques targeting trematode mitochondrial genes to detect and identify the causative organism. Clinical examinations include visual acuity, intraocular pressure, slit-lamp and dilated fundus exams, as well as ultrasound imaging when needed. Throughout the study, patients are monitored with regular eye exams and treated with topical antibiotics and steroids after surgery. Researchers measure detection of DNA in samples and organism identification as primary outcomes within six months. The study tracks participants from initial clinical assessment through surgery and laboratory analysis, aiming to improve understanding of trematode-related eye inflammation.
CONDITIONS
Brief Title
Ocular Fluid Work-up in Presumed Trematode Induced Granulomatous Uveitis
Research Team
A
Amnah A Amin, Master degree ophthalmology
A
Abdussalam M Abdullatif, Assistant Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here